Smith Andrew Alasdair
SEC insider (Form 3/4/5 filer). CIK 0001309614. Chief Operating Officer at Medicus Pharma Ltd. (MDCX). 4 reported Form 4/5 transactions since Sep 2024; latest on Sep 4, 2026. Located in W. CONSHOHOCKEN, PA.
Companies Smith Andrew Alasdair has filed insider reports for
- Medicus Pharma Ltd. (MDCX): Officer, Chief Operating Officer
Smith Andrew Alasdair
CIK: 0001309614
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
MDCX
Medicus Pharma Ltd.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Sep 4, 2026MDCX
Medicus Pharma Ltd.
AwardDirect735.3K shares at avg. $0.17$125K - Jun 3, 2026MDCX
Medicus Pharma Ltd.
AwardDirectStock Option (right to buy)
200K shares- - Mar 30, 2026MDCX
Medicus Pharma Ltd.
AwardDirectStock Option (right to buy)
50K shares- - Dec 16, 2025MDCX
Medicus Pharma Ltd.
AwardDirectStock Option (right to buy)
50K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 4, 2026 | MDCX Medicus Pharma Ltd. | Award | 735,294 | $0.17 | $125,368 | Direct |
| Jun 3, 2026 | MDCX Medicus Pharma Ltd. | Award Stock Option (right to buy) | 200,000 | - | - | Direct |
| Mar 30, 2026 | MDCX Medicus Pharma Ltd. | Award Stock Option (right to buy) | 50,000 | - | - | Direct |
| Dec 16, 2025 | MDCX Medicus Pharma Ltd. | Award Stock Option (right to buy) | 50,000 | - | - | Direct |
1-4 of 4 transactions